Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC [Phase 2]
Phase 2 trial evaluating camrelizumab with AC chemotherapy in brain metastases from driven gene-negative non-squamous non-small-cell lung ca…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: DM-CHOC-PEN for Brain Tumors in AYA Subjects [Phase 2]
Phase 2 trial update for DM-CHOC-PEN in adolescents and young adults with brain tumors, completed.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy [Phase 2]
Phase 2 clinical trial comparing stereotactic radiotherapy of the resection cavity to post-operative whole-brain radiotherapy for brain meta…
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Brigatinib Before Brain Irradiation Trial (B3i Trial) [Phase 2]
Phase 2 trial update for brigatinib before brain irradiation in patients with brain metastases and lung cancer has been terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer [Phase 1, Phase 2]
A dose-escalation trial is investigating hypofractionated stereotactic radiotherapy for brain metastases in patients with non-small cell lun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) [Phase 1, Phase 2]
Phase 1/2 trial evaluating glyburide vs placebo to prevent cerebral edema in patients undergoing radiosurgery for brain metastases; the stud…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases [Phase 2]
Phase 2 trial update evaluating pembrolizumab with ferumoxytol-enhanced MRI in patients with non-small cell lung cancer and brain metastases…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Neoadjuvant Immunotherapy in Brain Metastases [Phase 2]
Phase 2 neoadjuvant immunotherapy trial in adults with brain metastases was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: SIMT Stereotactic Radiosurgery Outcomes Study [NA]
Completed clinical trial update for SIMT Stereotactic Radiosurgery Outcomes Study; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating gefitinib with or without chemotherapy in brain metastases from non-small cell lung cancer is ongoing; results not …
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnife [Phase 2]
Phase 2 clinical trial update for hippocampal-sparing stereotactic radiosurgery of brain metastases using CyberKnife.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC [Phase 2]
Phase 2 trial assessing apatinib combined with radiotherapy in brain metastases from driver-gene negative non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: STAR Cape+BKM120 MBC With Brain Met [Phase 2]
A Phase 2 clinical trial update for STAR Cape+BKM120 in metastatic breast cancer with brain metastases has completed enrollment with results…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases [Phase 2]
Phase 2 trial investigating tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small cell lung cancer with bra…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases [Phase 2]
Phase 2 study of tesevatinib in subjects with non-small cell lung cancer and brain or leptomeningeal metastases has completed; results poste…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Camrelizumab Combined With Local Treatment in NSCLC Patients With BM [Phase 2]
Phase 2 trial update examining camrelizumab plus local treatment in stage IV non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases [Phase 2]
Phase 2 trial evaluating radiation therapy combined with thalidomide and temozolomide for patients with newly diagnosed brain metastases is …
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: HA-WBRT vs SRS in Patients With Multiple Brain Metastases [Phase 3]
Phase 3 clinical trial comparing HA-WBRT to SRS in patients with multiple brain metastases is ongoing; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine [Phase 3]
Phase 3 trial comparing etirinotecan pegol (NKTR-102) to physician's choice in metastatic breast cancer with stable brain metastases; study …
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases [Phase 3]
Phase 3 trial evaluating radiation therapy with or without RSR13 in patients with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases [Phase 2]
Phase 2 trial investigating concurrent dabrafenib and trametinib with stereotactic radiotherapy for BRAF mutation-positive melanoma with bra…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases [Phase 2]
Phase 2 trial comparing corticosteroids plus bevacizumab versus corticosteroids plus placebo for radionecrosis after radiosurgery in patient…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: A Proof-of-principle Study of HBO-SRS for Brain Metastases [NA]
A proof-of-principle study evaluating HBO-SRS for brain metastases has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of anlotinib and almonertinib as first-line therapy for brain metastases in EGFR mutation-…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases [Phase 2]
Phase 2 trial evaluating the combination of Radiation and Yervoy (ipilimumab) in melanoma patients with brain metastases has completed with …